Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Express Scripts
Queensland Health
Cantor Fitzgerald
Fish and Richardson

Generated: April 21, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: darunavir

« Back to Dashboard

darunavir Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Cipla Ltd darunavir hydrate 206288 150MG TABLET;ORAL
Hetero Labs Unit Iii darunavir ethanolate 202083 300MG TABLET;ORAL
Teva Pharms Usa darunavir ethanolate 202118 150MG TABLET;ORAL
Lupin Pharms darunavir ethanolate 202073 800MG TABLET;ORAL
Applicant Generic Name NDA Strength Dosage Form

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Cipla
Harvard Business School
Covington
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.